Emergo Therapeutics is a startup based in the United States.
Emergo Therapeutics is a company headquartered in the United States.
Emergo Therapeutics develops pharmaceutical treatments aimed at modulating and balancing the immune system, focusing on conditions related to cytokine dysregulation such as long COVID, influenza-like illnesses, and other respiratory viruses.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.